Literature DB >> 24227975

Ocular tumors: Triumphs, challenges and controversies.

Ralph C Eagle1.   

Abstract

Entities:  

Year:  2013        PMID： 24227975      PMCID： PMC3770221          DOI： 10.1016/j.sjopt.2013.06.002

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN： 1319-4534


× No keyword cloud information.
  60 in total

1.  Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.

Authors:  K Sisley; I G Rennie; M A Parsons; R Jacques; D W Hammond; S M Bell; A M Potter; R C Rees
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

2.  Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture.

Authors:  David H Abramson
Journal:  Br J Ophthalmol       Date:  2010-04       Impact factor: 4.638

3.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.

Authors:  M Diener-West; J D Earle; S L Fine; B S Hawkins; C S Moy; S M Reynolds; A P Schachat; B R Straatsma
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma.

Authors:  Carol L Shields; Aparna Ramasubramanian; Robert Rosenwasser; Jerry A Shields
Journal:  Retina       Date:  2009-09       Impact factor: 4.256

5.  Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography.

Authors:  Bita Esmaeli
Journal:  Br J Ophthalmol       Date:  2008-04       Impact factor: 4.638

6.  Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis.

Authors:  Jena J Steinle; Qiuhua Zhang; Karin Emmons Thompson; Jordan Toutounchian; C Ryan Yates; Carl Soderland; Fan Wang; Clinton F Stewart; Barrett G Haik; J Scott Williams; J Scott Jackson; Timothy D Mandrell; Dianna Johnson; Matthew W Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

7.  Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.

Authors:  Ralph C Eagle; Carol L Shields; Carlos Bianciotto; Pascal Jabbour; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-07-11

Review 8.  Clinical factors in the identification of small choroidal melanoma.

Authors:  Carol L Shields; Hakan Demirci; Miguel A Materin; Brian P Marr; Arman Mashayekhi; Jerry A Shields
Journal:  Can J Ophthalmol       Date:  2004-06       Impact factor: 1.882

9.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

10.  Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.

Authors:  Viet H Ho; Merrick I Ross; Victor G Prieto; Aisha Khaleeq; Stella Kim; Bita Esmaeli
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-08
View more
  1 in total

1.  Expression of Cell Cycle Markers and Proliferation Factors during Human Eye Embryogenesis and Tumorigenesis.

Authors:  Josipa Marin Lovrić; Natalija Filipović; Ljubo Znaor; Anita Rančić; Joško Petričević; Nenad Kunac; Violeta Šoljić; Mirna Saraga-Babić; Katarina Vukojević
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.